NWORTH, is a UK Clinical Research Collaboration (UKCRC) fully registered Clinical Trials Unit which specialises in the design, conduct, analysis and reporting of Phase II and III clinical trials. The unit is part of the Bangor Institute of Health and Medical Research (BIHMR) and sits in the School of Health Sciences within the College of Human Sciences.
The CTU is core funded by Health and Care Research Wales and our mission is to improve the health and well-being of the people of Wales and beyond by evaluating complex interventions in health and social care. We also aim to advance the theory and practice of randomised controlled trials and other rigorous designs for evaluation. NWORTH provides a Research Design and Conduct Service to Betsi Cadwaladr University Health Board and Powys Teaching Health Board.
NWORTH’s mission statement is to:
Improve the health and well-being of the people of Wales & beyond by evaluating interventions in health and social care and to advance the theory and practice of randomised controlled trials and other rigorous designs for evaluation.
The Unit’s ultimate aim is to make a difference, via our research outcomes, to people’s health across Wales and beyond.
In addition, we seek to contribute to methodological developments in experimental designs, by carrying out research to improve the external validity and efficiency of trial design and explore how the evidence generated from trials of complex interventions can be better implemented.
The Unit is committed to exploring research opportunities through the medium of Welsh and, via LLAIS, supports and carries out the translation and linguistic validation of Welsh language versions of health outcome measures.
Patient and Public Involvement and Engagement is central to everything that the Unit does. PARC-Bangor
The primary non-academic beneficiaries of the Unit’s research are patients/service users, their carers and families. Secondary beneficiaries include: NHS and social services in Wales and the rest of the UK; commercial companies; charitable and other funders; clinical guideline developers and policy makers; the economy and population of Wales and beyond.
The cornerstones of our approach are transparency, inclusivity, consistency and collaboration with the patients and the public, along with academic and non-academic partners and other beneficiaries to conduct rigorous research with the broadest possible impact.